OverT Bio received $120,000 in a G-Rex Grant to advance its solid tumor cell therapy development, supported by ScaleReady and its partners.
OverT Bio received $120,000 in a G-Rex Grant to advance its solid tumor cell therapy development, supported by ScaleReady and its partners.
11/22/24, 2:22 PM
Location
new yorkMoney raised
$120,000
Industry
biotechnology
Round Type
pre-seed
Investors
Cell Ready, Bio Techne Corporation, Wilson Wolf Manufacturing, Scale Ready
OverT Bio has been awarded a $120,000 G-Rex Grant to support its development of next-generation cell therapies for solid tumors. The grant is part of ScaleReady's $20 million program aimed at advancing cell and gene therapy manufacturing.
Company Info
Location
430 e 29th st 14fl
new york, new york, united states
Additional Info
OverT Bio, Inc., is a New York based biotechnology company developing effective and safe cellular therapies for solid tumors. Harnessing innovative pooled functional screening and synthetic genomics platforms (OverTargetTM and OverTCRTM), OverT Bio is uncovering new therapeutic targets and genetic enhancements in an unbiased, data-driven manner to deliver breakthrough medicines to cancer patients underserved by the standard of care.